Beckman Coulter Announces the Creation of Beckman Coulter Genomics
New Company Offers Comprehensive Genomic Services
Beckman Coulter, Inc. announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities.
"Through the creation of Beckman Coulter Genomics, we have successfully brought together the industry's leading genomic service providers to offer our customers the highest quality data and analysis," said Richard Creager, Ph.D., Beckman Coulter group vice president of Immunoassay, Molecular Diagnostics and Genomic Services.
Beckman Coulter Genomics has offices throughout North America and Europe.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Bruker to acquire the NanoString business in an asset deal
Ultrasonic Scientific Expands its Operations with the Appointments of Italien and Japanese Distributors
DNTOX receives €1.4 million seed funding for non-animal testing of chemicals - The new capital will be used to set up the test laboratories in Düsseldorf, aim for GLP accreditation and launch the test battery on the market
Oxford Instruments announces major technology licensing deal with GE Healthcare - Result will be powerful new tool for in vitro molecular analysis